Veeva Is Built for Product Launch. Adlib Makes the Content Work.

Product launches in life sciences aren’t just hard, they’re regulatory minefields wrapped in PDFs and layered with tight timelines. Every milestone, from evidence planning to commercial rollout, comes with a flood of content that needs to be accurate, structured, reviewed, and ready yesterday.

Christoph Bug, VP of Global Medical at Veeva laid out the complex logistics behind launching a new drug. Veeva is the platform the industry counts on to manage that complexity end to end. It connects medical, clinical, and commercial teams like nothing else.

But here’s the truth: launch success isn’t just about coordination. It’s about content readiness.

Today, many life sciences organizations still rely heavily on manual effort to process the content and data entering Veeva from a dozen different systems. This is prone to errors, rework, compliance risk, and launch delays.

Market leaders like AbbVie, Lilly, and other top pharmas trust Adlib to be the automation engine that makes Veeva work harder, faster, and smarter, by ensuring content is clean, structured, and ready at every step.

‍

Veeva: The Backbone of Life Sciences Launches‍

If you’re launching in pharma today, odds are you’re using Veeva. It’s the gold standard for keeping evidence plans, regulatory docs, stakeholder engagement, and field enablement on track.

Veeva powers:

• Clinical and post-approval study workflows
• Scientific communication platforms
• Medical content development and distribution
• Commercial content creation and stakeholder alignment
• Medical inquiry fulfillment and analytics

It’s built for launch excellence. But it wasn’t built to transform scanned PDFs into validated, metadata-rich, submission-ready content at scale.

That’s the job for Adlib.

‍

Where Launch Timelines Slip: Content Bottlenecks

Let’s call it what it is: content is the biggest unspoken risk in drug launches.

• Evidence reports that show up as scans, not searchable files
• Scientific narratives with inconsistent references and formatting
• Promo materials delayed in MLR because metadata is missing
• Information requests that require manual hunting through outdated documents

Each of these steps is content-heavy. Highly regulated. And totally capable of burning weeks (or worse), delaying approval entirely.

‍

Why Speed Matters in Life Sciences

Speed is both: a competitive advantage and a financial imperative in life sciences.

The average cost to bring a drug to market topped $2.3B in 2022, and companies don’t start seeing meaningful ROI until 6–10 years after launch.

With $1 million lost every day a drug is delayed, every week shaved off R&D, regulatory review, or content readiness translates to millions in recovered value. Add in a fixed 20-year patent clock, and the fact that the most profitable years fall within the narrow 1–3 year market launch window, and it’s clear: the organizations that move the fastest are the ones that win.

This is why efficiency and automation across content-heavy, compliance-critical workflows isn’t a “nice to have.” It’s how you protect revenue, recover investment, and scale impact.

‍

Adlib: The Automation Layer Veeva Didn’t Know It Needed

Adlib doesn’t replace Veeva. It maximizes its potential.

Adlib transforms messy, inconsistent documents into structured, audit-ready assets, and ensures your content is clean, compliant, and Veeva-ready.

Here’s how it plays out:

Upstream, before launch

• Converts raw trial documents into submission-ready formats
• Applies metadata, bookmarks, and version control without human error
• Ensures PDF/A and 21 CFR Part 11 compliance automatically

Downstream, after go-live

• Automates MLR-friendly formatting for commercial materials
• Assembles content bundles for rapid stakeholder engagement
• Accelerates response times for medical info requests using pre-approved content
• Powers AI-readiness by structuring the content AI depends on
• Automates plain-language summaries, product labeling, and patient guides

You don’t need more people manually cleaning documents. You need automation that plugs into your Veeva stack and gets out of the way.

‍

Veeva + Adlib: Launch-Ready from Day One‍

Let’s simplify:

• Veeva is the launch platform.
• Adlib is the content engine that keeps it running at speed.

Veeva aligns your teams. Adlib gets your content in shape so those teams can move faster, avoid costly errors, and stay ahead of the next regulatory review.

Launching a product? You’ve got one shot to get it right. Don’t let documents be the reason you miss.